ketamine
Commercial- Indications
- Depression, Anxiety, PTSD, Trauma
Company intelligence / Profile preview
Optimind Pharma Corp. operates clinics in Canada offering psychedelic-enhanced psychotherapy—including ketamine and psilocybin-assisted treatments—as well as medical cannabis for a range of mental health conditions such as PTSD, anxiety, depression, and other disabilities. The company focuses on legal, controlled administration of these therapies through its clinical network. No specific clinical trial results are disclosed; the business appears to be focused on commercial service delivery rather than drug development.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optimind Pharma Corp..